The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A. [electronic resource]
Producer: 20210305ISSN:- 2072-6651
- Administration, Intravesical
- Biomarkers -- analysis
- Botulinum Toxins, Type A -- administration & dosage
- Diabetes Complications -- complications
- Efferent Pathways -- drug effects
- Humans
- Inflammation
- Risk Factors
- Treatment Outcome
- Urinary Bladder -- drug effects
- Urinary Bladder, Overactive -- drug therapy
- Urodynamics -- drug effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.